Fortrea Holdings (FTRE) Current Assets (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Current Assets came in at $923.6 million in Q2 2026, down 3.79% YoY from $960.0 million in Q2 2025, and up 4.78% on a QoQ basis from $881.5 million in Q1 2026.
Fortrea Holdings (FTRE) Current Assets (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has 5 years of Current Assets data on file, last reported at $923.6 million in Q2 2026.
- Quarterly Current Assets fell 3.79% year-over-year to $923.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $923.6 million (down 3.79% YoY) and the FY2025 annual result came in at $897.2 million, down 5.38% from the prior year.
- Current Assets grew to $923.6 million in Q2 2026, from $881.5 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $1.3 billion in Q3 2023 to a low of $881.5 million in Q1 2026.
- A 5-year average of $1.0 billion and a median of $954.1 million in 2024 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2024 — Current Assets declined 27.92% — and 2025, when it rose 8.14%.
- Tracing FTRE's Current Assets over 5 years: stood at $1.2 billion in 2022, then gained by 0.31% to $1.3 billion in 2023, then decreased by 24.19% to $948.2 million in 2024, then fell by 5.38% to $897.2 million in 2025, then grew by 2.94% to $923.6 million in 2026.
- The last three Current Assets figures came in at $923.6 million (Q2 2026), $881.5 million (Q1 2026), and $897.2 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Fortrea Holdings | 1.66 Bn | 1.49 Bn | 139.20 Mn | 923.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 923.60 Mn |
| Mar 31, 2026 | 881.50 Mn |
| Dec 31, 2025 | 897.20 Mn |
| Sep 30, 2025 | 918.50 Mn |
| Jun 30, 2025 | 960.00 Mn |
| Mar 31, 2025 | 970.30 Mn |
| Dec 31, 2024 | 948.20 Mn |
| Sep 30, 2024 | 936.90 Mn |
| Jun 30, 2024 | 887.70 Mn |
| Mar 31, 2024 | 1.20 Bn |
| Dec 31, 2023 | 1.25 Bn |
| Sep 30, 2023 | 1.26 Bn |
| Jun 30, 2023 | 1.23 Bn |
| Dec 31, 2022 | 1.25 Bn |